10x Genomics, Inc.
$24.59
▲
1.27%
2026-04-21 09:58:00
www.10xgenomics.com
NMS: TXG
Explore 10x Genomics, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$3.14 B
Current Price
$24.59
52W High / Low
$26.45 / $7.25
Stock P/E
—
Book Value
$6.24
Dividend Yield
—
ROCE
-12.49%
ROE
-5.78%
Face Value
—
EPS
$-0.35
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
1,178
Beta
2.17
Debt / Equity
10.59
Current Ratio
4.46
Quick Ratio
4.09
Forward P/E
139.62
Price / Sales
4.62
Enterprise Value
$2.53 B
EV / EBITDA
-39.54
EV / Revenue
3.94
Rating
Buy
Target Price
$20.62
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | GoodRx Holdings, Inc. | $2.37 | 26.67 | $811.9 M | — | 7.56% | 4.54% | $5.81 / $1.77 | $1.81 |
| 2. | OneMedNet Corporation | $0.94 | — | $46.93 M | — | 361.52% | 29.62% | $4.22 / $0.3 | $-0.06 |
| 3. | HeartBeam, Inc. | $0.92 | — | $37.8 M | — | -812.1% | -9.87% | $4 / $0.54 | $0.07 |
| 4. | Aclarion, Inc. | $3.55 | — | $7.74 M | — | -54.95% | -1.05% | $12.03 / $2.34 | $15.02 |
| 5. | Bullfrog AI Holdings, Inc. | $0.99 | — | $18.34 M | — | -308.69% | -1.83% | $2.04 / $0.43 | $0.19 |
| 6. | Mangoceuticals, Inc. | $0.51 | — | $7.43 M | — | -62.34% | -1.42% | $2.88 / $0.16 | $1.13 |
| 7. | Zhongchao Inc. | $2.06 | — | $7.52 M | — | -1.4% | -24.88% | $12.18 / $1.44 | $6.39 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 166.03 M | 149 M | 172.91 M | 154.88 M | 165.02 M | — |
| Operating Profit | -19.54 M | -32.24 M | -10.57 M | -48.53 M | -49.84 M | — |
| Net Profit | -16.25 M | -27.47 M | 34.54 M | -34.36 M | -49.03 M | — |
| EPS in Rs | -0.14 | -0.23 | 0.29 | -0.29 | -0.42 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 642.82 M | 610.78 M | 618.73 M | 516.41 M |
| Operating Profit | -110.89 M | -194.56 M | -204.35 M | -167.94 M |
| Net Profit | -43.54 M | -182.63 M | -255.1 M | -166 M |
| EPS in Rs | -0.37 | -1.55 | -2.17 | -1.41 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 1.04 B | 918.64 M | 965.14 M | 1.03 B |
| Total Liabilities | 245.04 M | 208.5 M | 224.1 M | 223.24 M |
| Equity | 796.33 M | 710.13 M | 741.04 M | 805.74 M |
| Current Assets | 684.45 M | 584.39 M | 596.02 M | 635.03 M |
| Current Liabilities | 153.45 M | 117.63 M | 127.16 M | 130.96 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 136.05 M | 6.66 M | -15.2 M | -33.61 M |
| Investing CF | -13.44 M | -32.63 M | 133.49 M | -350.89 M |
| Financing CF | 6.8 M | 10.91 M | 13.67 M | 15.82 M |
| Free CF | 130.12 M | -6.73 M | -64.72 M | -165.27 M |
| Capex | -5.93 M | -13.39 M | -49.52 M | -131.66 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -1.28% | 19.81% | — | — |
| Earnings Growth % | 28.41% | -53.67% | — | — |
| Profit Margin % | -29.9% | -41.23% | -32.15% | — |
| Operating Margin % | -31.85% | -33.03% | -32.52% | — |
| Gross Margin % | 67.86% | 66.15% | 76.69% | — |
| EBITDA Margin % | -21.94% | -33.15% | -24.88% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.